-
CUDA Yanqi Lake Conference | Professor Xiaodong Wen : From Evidence to Practice — How Real-World Precision Therapy Addresses Clinical Challenges in Urologic Oncology
Randomized controlled trials (RCTs), regarded as the “gold standard” of evidence-based medicine, serve as the cornerstone for establishing oncology treatment guidelines. However, it is equally important to recognize that the strict inclusion and exclusion criteria of RCTs often create a significant gap between trial populations and the realities of everyday clinical practice, where many patients…
-
From Treatment to Prevention: How China’s Leading Clinicians Are Redefining Colorectal Cancer Care Globally
Chaired by Prof. Kefeng Ding, The Second Affiliated Hospital Zhejiang University School of Medicine and other renowned scholars, dozens of authoritative experts attended the conference beside West Lake. They shared…
-
“Deep Dive Debate” | After Achieving pCR with Immunotherapy in TNBC, Should Adjuvant Immunotherapy Be Continued or Stopped?
With the success of landmark clinical studies such as KEYNOTE-522, neoadjuvant treatment for early-stage triple-negative breast cancer (TNBC) has fully entered the era of immunotherapy combined with chemotherapy. While this strategy has significantly improved pathological complete response (pCR) rates and delivered substantial survival benefits, it has also raised one of the most debated questions in…
-
2026 CSCO BC Guideline Highlights | Professor Jiayi Chen: Key Updates in Breast Cancer Radiotherapy
The 2026 National Breast Cancer Conference was held in Beijing from April 10–12, during which major updates to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2026 (CSCO BC Guidelines 2026) were officially released. At the meeting, Professor Jiayi Chen from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, reviewed and interpreted…
-
2026 CSCO BC Guideline Highlights | Professor Chunfang Hao: Key Updates in Salvage Endocrine Therapy for HR-Positive Advanced Breast Cancer — Multi-Directional Strategies, Precision Assessment, Optimized Combinations, and Sequential Multi-Target Therapy
The 2026 National Breast Cancer Conference was held in Beijing from April 10–12, during which the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2026 (CSCO BC Guidelines 2026) underwent major updates. At the meeting, Professor Chunfang Hao from Tianjin Medical University Cancer Institute and Hospital delivered a comprehensive overview of the latest advances…
-
2026 CSCO BC Guideline Highlights | Professor Kun Wang: Key Updates in Neoadjuvant and Adjuvant Management of HER2-Positive Early Breast Cancer
The 2026 National Breast Cancer Conference was held in Beijing from April 10–12, during which important updates to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2026 (CSCO BC Guidelines 2026) were officially released. At the meeting, Professor Kun Wang from Guangdong Provincial People’s Hospital presented and interpreted the latest updates in neoadjuvant…
-
2026 CSCO Guidelines Conference | Academician Jinming Yu: Strengthening China-Based Evidence, Advancing Global Guideline Outreach, and Bringing Standardized Cancer Care to the Grassroots Level
The 2026 Chinese Society of Clinical Oncology (CSCO) Guidelines Conference was grandly held in Harbin from April 24–25. Bringing together more than a thousand experts, the meeting focused on guideline updates, intelligent healthcare, and multidisciplinary collaboration, with a strong emphasis on extending standardized cancer care to grassroots medical institutions and narrowing regional disparities in oncology…
-
2026 HOT Conference | Professor Zhenzhen Liu: From Live Surgical Demonstrations to Specialty Center Development — Advancing Breast Cancer Care on Multiple Fronts
With the warmth of spring invigorating the Central Plains, the 18th Northern Breast Cancer HOT Conference was successfully held in Zhengzhou from April 16–18, 2026. During the meeting, Oncology Frontier conducted an exclusive interview with the conference chair, Professor Zhenzhen Liu from Henan Cancer Hospital. In the interview, she discussed the conference’s major highlights, the…
Connecting Medical Expertise through Media